Question to the Department for International Trade:
To ask the Secretary of State for International Trade, pursuant to the Answer of 28 November 2016 to Question 54496, if he will provide a list of the representatives from the pharmaceuticals sector that officials of his Department have met since July 2016.
DIT has regular consultation with representatives from the UK pharmaceuticals sector. In particular a UK/ EU working group was established after the EU referendum to manage a programme of work to inform the transition. The steering group is co-chaired by GSK Chief Executive Sir Andrew Witty and Astra Zeneca Chief Executive Pascal Soriot and is the key forum for discussions between government and the life sciences industry on matters relating to exiting the EU.
In addition a large number of bilateral meetings have been held between DIT and pharmaceutical industry officials.